跳至主要内容
临床试验/NCT00772291
NCT00772291已完成3 期

Chronic Pain Management After Herniorraphy:Pregabalin vs Placebo. A Double-blinded Randomised Controlled Clinical Trial.

Erasmus Medical Center1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2007年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
140
试验地点
1
主要终点
pain

研究概览

简要总结

Nowadays, chronic pain mainly as a result of iatrogenic nerve damage is generally considered as the most frequent complication after inguinal hernia surgery. The primary objective of this randomised double-blind placebo-controlled trial is to investigate whether pregabalin reduces pain in patients with chronic pain of neuropathic origin after herniorraphy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of unilateral inguinal herniotomy
  • Establishment of neuropathic character of chronic pain by means the LANSS painscore and DN4 score
  • Abnormal sensitivity (allodynia, dysesthesia, hypoesthesia or dysesthesia) in or around the incisional area
  • Duration pain ≥ 3 months
  • Medial or lateral inguinal hernia
  • Age ≥ 18 years
  • VAS score ≥ 40 mm on Vas scale on which they indicate 'how unpleasant or disturbing the worst pain was that they had today'
  • Grade III or IV pain and discomfort on the 4-point pain and discomfort scale
  • Informed consent (addendum V)

排除标准

  • Participation in another trial
  • Age < 18 years
  • Cognitive disfunction
  • Patient is unable to speak Dutch
  • Hereditary problems of galactose intolerance, Lapp lactase deficiency or glucosegalactose malabsorption
  • Patient classified as American Society of Anaesthesiologist Class 4
  • Renal impairment

研究组 & 干预措施

placebo

Placebo Comparator

干预措施: placebo (Drug)

pregabalin

Active Comparator

干预措施: pregabalin (Drug)

结局指标

主要结局

pain

时间窗: 8 weeks

次要结局

  • quantitative sensory testing (QST) accuracy in testing the inguinal region(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

hasan eker

Prof. Dr. J.F. Lange

Erasmus Medical Center

研究点 (1)

Loading locations...

相似试验